TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16966687

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus carboplatin
Number of subjects: 356

Group type: COMPARATOR
Intervention: Carboplatin
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 356
Study: 12937009

Group type: EXPERIMENTAL
Intervention: Cefaclor (CFC) 20 mg/kg
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanic acid (AMX/CA) 20 mg/kg (4:1 ratio)
Number of subjects: 67
Study: 10321661

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (loading dose of 100 mg followed by continuous infusion of 0.18 mg/kg/hr, reduced to 0.08 mg/kg/hr after shock reversal)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (physiologic saline solution)
Number of subjects: 40
Study: 7577590

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 0.05% cream applied once-daily
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 0.05% cream applied twice-daily
Number of subjects: 270

Group type: COMPARATOR
Intervention: Fluticasone propionate 0.05% cream applied once-daily with vehicle cream
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 0.05% cream applied once-daily and twice-daily
Number of subjects: 270
Study: 1836679

Group type: EXPERIMENTAL
Intervention: Lordotic posture facilitated by a lumbar roll
Number of subjects: 210

Group type: COMPARATOR
Intervention: Kyphotic posture facilitated by a flat foam cushion
Number of subjects: 210
Study: 7042373

Group type: EXPERIMENTAL
Intervention: labetalol/hydrochlorothiazide
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: propranolol/hydralazine/hydrochlorothiazide
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: propranolol/hydralazine
Number of subjects: 34
Study: 31181186

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 81
Study: 28109092

Group type: EXPERIMENTAL
Intervention: Preoperative mechanical bowel preparation
Number of subjects: 148

Group type: COMPARATOR
Intervention: No preoperative mechanical bowel preparation
Number of subjects: 148
Study: 26231302

Group type: EXPERIMENTAL
Intervention: Sealing
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Replacement
Number of subjects: 26

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 26
Study: 23059373

Group type: EXPERIMENTAL
Intervention: Adenosine 5'-monophosphate (AMP) challenge
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Methacholine challenge
Number of subjects: 18
Study: 22093197

Group type: EXPERIMENTAL
Intervention: Nonemergency PCI at non-SOS hospitals
Number of subjects: 3690

Group type: COMPARATOR
Intervention: Nonemergency PCI at SOS hospitals
Number of subjects: 3690
Study: 19228431

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate and booster 23-valent polysaccharide vaccine
Number of subjects: 148

Group type: COMPARATOR
Intervention: Comparison group (no vaccination)
Number of subjects: 148
Study: 16511715

Group type: EXPERIMENTAL
Intervention: 0.5% isotonic solution of sodium carboxymethylcellulose (CMC)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Balanced salt solution (control)
Number of subjects: 19
Study: 12975626

Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulation
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Prescription medications
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Self-care education
Number of subjects: 28
Study: 10731269

Group type: EXPERIMENTAL
Intervention: Intracoronary nicardipine (200 mcg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Intracoronary diltiazem (1 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Intracoronary verapamil (200 mcg)
Number of subjects: 9
Study: 8617088

Group type: EXPERIMENTAL
Intervention: Wire-guided catheters (WGC)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Non-wire-guided catheters (non-WGC)
Number of subjects: 67
Study: 1472184

Group type: EXPERIMENTAL
Intervention: Adjuvant psychological therapy
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 174
Study: 6363397

Group type: EXPERIMENTAL
Intervention: Amoxapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study: 31259608

Group type: EXPERIMENTAL
Intervention: Acetazolamide 125 mg twice daily, day of ascent dosing
Number of subjects: 104

Group type: COMPARATOR
Intervention: Acetazolamide 125 mg twice daily, night before dosing
Number of subjects: 104
Study: 29723022

Group type: EXPERIMENTAL
Intervention: Supported education services delivered by veteran peers
Number of subjects: 33

Group type: COMPARATOR
Intervention: Matched attention of generalized support without supporting educational goals (Control)
Number of subjects: 33
Study: 26811067

Group type: EXPERIMENTAL
Intervention: Primary microsurgical repair of the injured nerve with the additional use of a chitosan nerve tube
Number of subjects: 100

Group type: COMPARATOR
Intervention: Direct tension free microsurgical repair of the injured nerve alone
Number of subjects: 100
Study: 24512643

Group type: EXPERIMENTAL
Intervention: PSA testing restricted to younger men (age cut-offs of 60, 65, and 70)
Number of subjects: 3936

Group type: EXPERIMENTAL
Intervention: PSA levels below 1 ng/ml
Number of subjects: 3936
Study: 21898012

Group type: EXPERIMENTAL
Intervention: Floppy Nissen fundoplication (group I, n = 50)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Toupet fundoplication (group II, n = 50)
Number of subjects: 100
Study: 19147527

Group type: EXPERIMENTAL
Intervention: Enoxaparin 1.5 mg/kg once daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Enoxaparin 1 mg/kg twice daily (Control)
Number of subjects: 120
Study: 17592287

Group type: EXPERIMENTAL
Intervention: Intermittent Sequential Pneumatic Compression (ISPC) device during pneumoperitoneum (PP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group without ISPC
Number of subjects: 20
Study: 16146494

Group type: EXPERIMENTAL
Intervention: IFN-beta-1a 44 microg subcutaneous three times weekly (t.i.w.) for 12 months
Number of subjects: 21

Group type: COMPARATOR
Intervention: Post-treatment follow-up without IFN-beta-1a
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: During treatment and follow-up
Number of subjects: 21
Study: 11890233

Group type: EXPERIMENTAL
Intervention: Urological trainees
Number of subjects: 122

Group type: COMPARATOR
Intervention: Consultants
Number of subjects: 122

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 122
Study: 9784675

Group type: EXPERIMENTAL
Intervention: Outpatient treatment with low‐molecular‐weight heparin
Number of subjects: 28

Group type: COMPARATOR
Intervention: In-hospital treatment with unfractionated heparin
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Outpatient treatment
Number of subjects: 28
Study: 7840824

Group type: COMPARATOR
Intervention: 0 mg i.v. of murine anti EGF‐R IgG2a mab EMD 55900
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 20 mg i.v. of murine anti EGF‐R IgG2a mab EMD 55900
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 100 mg i.v. of murine anti EGF‐R IgG2a mab EMD 55900
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 400 mg i.v. of murine anti EGF‐R IgG2a mab EMD 55900
Number of subjects: 16
Study: 3340118

Group type: EXPERIMENTAL
Intervention: 12 weeks of chemohormonal therapy (cyclophosphamide, methotrexate, fluorouracil, vincristine, prednisone, doxorubicin, tamoxifen)
Number of subjects: 205

Group type: COMPARATOR
Intervention: 36 weeks of chemotherapy (cyclophosphamide, methotrexate, fluorouracil, vincristine, prednisone)
Number of subjects: 205
Study: 31770007

Group type: EXPERIMENTAL
Intervention: Moderate exergame training (11‐13 perceived exertion)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vigorous exergame training (14‐16 perceived exertion)
Number of subjects: 20
Study: 30458880

Group type: EXPERIMENTAL
Intervention: Alternative resuscitation strategies
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Microcirculatory perfusion parameters
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Microcirculatory perfusion
Number of subjects: 207
Study: 27575584

Group type: EXPERIMENTAL
Intervention: Whole‐body cold mist shower therapy
Number of subjects: 121
Study: 25611597

Group type: EXPERIMENTAL
Intervention: Standardized physiotherapy protocol (EG)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Typical, non‐standardized physiotherapy treatment (CG)
Number of subjects: 16
Study: 23413448

Group type: EXPERIMENTAL
Intervention: Critical appraisal education program (1-day, small group discussion)
Number of subjects: 0
Study: 20832867

Group type: EXPERIMENTAL
Intervention: 5 lux light condition
Number of subjects: 23

Group type: COMPARATOR
Intervention: 10,000 lux light condition
Number of subjects: 23

Group type: COMPARATOR
Intervention: 100 lux light condition
Number of subjects: 23
Study: 18680695

Group type: EXPERIMENTAL
Intervention: Screened for HLA‐B*5701 before starting abacavir treatment
Number of subjects: 1956

Group type: COMPARATOR
Intervention: Conventional follow-up (Control)
Number of subjects: 1956

Group type: EXPERIMENTAL
Intervention: Epicutaneous patch testing for immunological confirmation
Number of subjects: 1956
Study: 17154749

Group type: EXPERIMENTAL
Intervention: Exposure-based treatments
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Reduction in probability bias
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Reduction in cost bias
Number of subjects: 53
Study: 12671943

Group type: EXPERIMENTAL
Intervention: 0.2-Hz repetitive transcranial magnetic stimulation (rTMS) over Cz (motor cortical stimulation)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: 0.2-Hz repetitive transcranial magnetic stimulation (rTMS) over inion (occipital stimulation)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 85
Study: 10557020

Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg daily for 12 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg daily
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg daily and Placebo
Number of subjects: 19
Study: 8533749

Group type: EXPERIMENTAL
Intervention: Mass treatment and behavior modification campaign
Number of subjects: 1417

Group type: EXPERIMENTAL
Intervention: Female children
Number of subjects: 1417

Group type: EXPERIMENTAL
Intervention: Familial cattle ownership and having one or more siblings with trachoma at baseline
Number of subjects: 1417

Group type: EXPERIMENTAL
Intervention: Sustainably clean face
Number of subjects: 1417

Group type: EXPERIMENTAL
Intervention: Improved face-washing plus antibiotic treatment
Number of subjects: 1417
Study: 1882473

Group type: EXPERIMENTAL
Intervention: Low Level Laser therapy (Galium‐Aluminium‐Arsenide laser, 30 mW/830 nm, Unilaser 2000 3B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 6350479

Group type: EXPERIMENTAL
Intervention: Etretinate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study: 31514977

Group type: EXPERIMENTAL
Intervention: Auricular acupressure using ear pellets on 5 acupoints for 8 weeks
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 65
Study: 29075780

Group type: EXPERIMENTAL
Intervention: irinotecan plus panitumumab (IrPan)
Number of subjects: 308

Group type: COMPARATOR
Intervention: irinotecan
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: HER3-high, AREG/EREG-high tumors with panitumumab
Number of subjects: 308

Group type: COMPARATOR
Intervention: HER3-low, AREG/EREG-low tumors
Number of subjects: 308
Study: 28116431

Group type: EXPERIMENTAL
Intervention: Koukuining granules, taken orally after a meal, 3 times a day, 1 bag each time, for 10 days, repeated after 3 days of interval.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vitamin C and compound vitamin B2, taken orally for 2 courses.
Number of subjects: 100
Study: 25060415

Group type: EXPERIMENTAL
Intervention: Blood pressure (BP) <110/60 mm Hg
Number of subjects: 3947

Group type: EXPERIMENTAL
Intervention: Optimal blood pressure target of 140/78 mm Hg
Number of subjects: 3947

Group type: EXPERIMENTAL
Intervention: U-shaped relation between BP and ACM
Number of subjects: 3947
Study: 23204609

Group type: EXPERIMENTAL
Intervention: Extended bedtime (10 hr) for 4 nights (EXT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Habitual bedtimes (HAB) for 4 nights
Number of subjects: 18
Study: 20685507

Group type: EXPERIMENTAL
Intervention: Test formulation (generic glimepiride 2 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Reference formulation (branded glimepiride 2 mg)
Number of subjects: 23
Study: 18714738

Group type: EXPERIMENTAL
Intervention: Standard treatment consisting of a 7-day administration of one proton pump inhibitor and 2 out of 3 antibiotics (amoxicillin, clarithromycin, metronidazole)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quadruple treatment regimen consisting of bismuth salts, tetracycline, metronidazole, and proton pump inhibitor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New antibiotics (levofloxacin and rifabutin) for Hp eradication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eradication treatment assessed with urease or breath test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active search for Hp infection in asymptomatic population
Number of subjects: 0
Study: 15929666

Group type: EXPERIMENTAL
Intervention: Thyroidectomies without searching for the EBSLN (G1)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Thyroidectomies searching for the EBSLN (G2)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (G3)
Number of subjects: 100
Study: 12870120

Group type: EXPERIMENTAL
Intervention: Long-cycle structured intermittent therapy (SIT; 4 weeks without HAART followed by 8 weeks with HAART)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Continuous highly active antiretroviral therapy (HAART)
Number of subjects: 41
Study: 10604411

Group type: EXPERIMENTAL
Intervention: Cricopharyngeal myotomy and tracheal cartilaginous implantation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (no surgical intervention)
Number of subjects: 21
Study: 7560477

Group type: EXPERIMENTAL
Intervention: Continuous Negative External Pressure (CNEP)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Positive End-Expiratory Pressure (PEEP) 10 cmH2O
Number of subjects: 15

Group type: COMPARATOR
Intervention: Zero End-Expiratory Pressure (ZEEP)
Number of subjects: 15
Study: 1777297

Group type: EXPERIMENTAL
Intervention: Anxiety management booklet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual treatment from general practitioner
Number of subjects: 0
Study: 7048668

Group type: EXPERIMENTAL
Intervention: DEC (diethylcarbamazine) given in spaced doses (once weekly, monthly, or bi-monthly)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: DEC (diethylcarbamazine) at a total dose of 36-48 mg/kg
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: DEC (diethylcarbamazine) at a total dose of 72 mg/kg
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Levamisole (3 mg/kg) prior to DEC (6 mg/kg/day for 7 days)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Retreatment with DEC (6 mg/kg/day for 7 days)
Number of subjects: 78
Study: 6437366

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Lithium carbonate and imipramine combination
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study: 30566708

Group type: EXPERIMENTAL
Intervention: Large spot laser
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard spot laser
Number of subjects: 40
Study: 26546298

Group type: EXPERIMENTAL
Intervention: Hysteroscopic local anesthetic intrauterine cornual block (ICOB) plus direct local anesthetic cervical block (DCB) using 1 mL 3% mepivacaine plus 1 mL 0.5% bupivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group receiving DCB plus ICOB with 2 mL of placebo (saline)
Number of subjects: 0
Study: 23465084

Group type: EXPERIMENTAL
Intervention: Moderate doses of lithium plus optimized treatment (OPT)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Optimized treatment (OPT) alone
Number of subjects: 264
Study: 22154548

Group type: EXPERIMENTAL
Intervention: Structured pre-operative interview conducted by operating room nurses
Number of subjects: 335

Group type: COMPARATOR
Intervention: Current situation without any formal intervention (control group)
Number of subjects: 335
Study: 20626016

Group type: EXPERIMENTAL
Intervention: Child-targeted intervention involving massage and humor therapy
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Identical child intervention plus a parent intervention involving massage and relaxation/imagery
Number of subjects: 178

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 178
Study: 17597711

Group type: EXPERIMENTAL
Intervention: GI181771X (selective CCK‐A agonist)
Number of subjects: 701

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 701
Study: 16372905

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV+)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (only static exercise)
Number of subjects: 24
Study: 12218519

Group type: EXPERIMENTAL
Intervention: 1% lidocaine pretraumatic injection
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 1% lidocaine posttraumatic injection
Number of subjects: 17

Group type: COMPARATOR
Intervention: Saline (placebo) pretraumatic injection
Number of subjects: 17

Group type: COMPARATOR
Intervention: Saline (placebo) posttraumatic injection
Number of subjects: 17
Study: 11783195

Group type: EXPERIMENTAL
Intervention: Salvia injection (SI)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Integrated traditional Chinese and western medicine (TCM‐WM)
Number of subjects: 90
Study: 8684533

Group type: EXPERIMENTAL
Intervention: Steroid treatment for an average period of 18 months
Number of subjects: 46

Group type: COMPARATOR
Intervention: No steroid treatment
Number of subjects: 46
Study: 1933182

Group type: EXPERIMENTAL
Intervention: J pouch
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: S pouch
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: W pouch
Number of subjects: 61

Group type: COMPARATOR
Intervention: Mucosal proctectomy
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: J and W pouches
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Pouchitis
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Pouch evacuation
Number of subjects: 61
Study: 6295861

Group type: EXPERIMENTAL
Intervention: 150 mg Ranitidine at night
Number of subjects: 78

Group type: COMPARATOR
Intervention: Low-dose antacid when necessary
Number of subjects: 78
Study: 30248040

Group type: EXPERIMENTAL
Intervention: Home exercise program taught by physiotherapist
Number of subjects: 80

Group type: COMPARATOR
Intervention: Home exercise program (brochure provided by orthopedist)
Number of subjects: 80
Study: 27398918

Group type: EXPERIMENTAL
Intervention: GAA 15 training program (15 minutes of neuromuscular training exercises, twice weekly for 8 weeks)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: GAA 15 training program
Number of subjects: 78

Group type: COMPARATOR
Intervention: Usual team training (control)
Number of subjects: 78
Study: 25375311

Group type: EXPERIMENTAL
Intervention: SPI-guided analgesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard analgesia
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 23999980

Group type: EXPERIMENTAL
Intervention: Primary care management plus TENS (transcutaneous electrical nerve stimulation) used once a day for 45 minutes over six weeks
Number of subjects: 241

Group type: COMPARATOR
Intervention: Primary care management only (consultation with a general practitioner followed by information and advice on exercises)
Number of subjects: 241
Study: 21529831

Group type: EXPERIMENTAL
Intervention: Mobile device balance game for 10 minutes
Number of subjects: 40

Group type: COMPARATOR
Intervention: No warm-up
Number of subjects: 40
Study: 18178111

Group type: EXPERIMENTAL
Intervention: Therapeutic shortwave diathermy (SWD), 20 min/session, 3 sessions/week for 3 weeks
Number of subjects: 113

Group type: COMPARATOR
Intervention: Sham shortwave diathermy (SWD)
Number of subjects: 113
Study: 16448427

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: PKRP
Number of subjects: 57
Study: 12757534

Group type: EXPERIMENTAL
Intervention: Amicus
Number of subjects: 40

Group type: COMPARATOR
Intervention: Spectra
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Amicus and Spectra
Number of subjects: 40
Study: 11509470

Group type: EXPERIMENTAL
Intervention: 256-mg ferrous sulfate daily for 4 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 9354196

Group type: EXPERIMENTAL
Intervention: Famotidine 10 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ranitidine 75 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 7958150

Group type: EXPERIMENTAL
Intervention: Single oral dose of fluconazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single intravaginal dose of 500 mg clotrimazole
Number of subjects: 0
Study: 2443762

Group type: EXPERIMENTAL
Intervention: Bleomycin
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 34
Study: 31591045

Group type: EXPERIMENTAL
Intervention: Acupressure at Sanyinjiao for 8 weeks (experimental group)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Sham group without acupressure (control group)
Number of subjects: 53
Study: 30457060

Group type: EXPERIMENTAL
Intervention: Gonadotrophin-releasing hormone agonist (GnRHa)
Number of subjects: 60
Study: 28431559

Group type: EXPERIMENTAL
Intervention: RFB/RKB + RS
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: RFB
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: RFB/RKB
Number of subjects: 21

Group type: COMPARATOR
Intervention: WWB
Number of subjects: 21
Study: 25534065

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention based on Teaching Recovery Techniques (TRT)
Number of subjects: 482

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 482
Study: 23269410

Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 9

Group type: COMPARATOR
Intervention: No Exercise (NE)
Number of subjects: 9